U.S., March 12 -- An application to own the trademark for 'RACYLMO' has been filed on Dec. 07, 2023.
Owner(s):
Sumitomo Pharma Co., Ltd.; 6-8, Doshomachi 2-chome,, Chuo-ku, Osaka-shi Osaka 541-0045, JAPAN
Goods and/or Services:
For: Pharmaceutical preparations for the central nervous system; cells for medical use
Class(es): 005, 006, 018, 044, 046, 051, 052
Mark Drawing Type: 4 - STANDARD CHARACTER MARK
https://eog-tmng.uspto.gov/#/issueDate=2025-03-11&serialNumber=79388762
Disclaimer: Curated by HT Syndication....